Siemens N Antiserum to Human C1-Inhibitor - HSA Registration DE0017820
Access comprehensive regulatory information for Siemens N Antiserum to Human C1-Inhibitor in the Singapore medical device market through Pure Global AI's free database. This CLASS B IVD medical device is registered under HSA registration number DE0017820 and owned by Siemens Healthcare Diagnostics Products GmbH. The device was registered on January 26, 2016.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
N Antiserum to Human C1-Inhibitor is an in vitro diagnostic reagent for the quantitative determination of C1-Inhibitor concentration as aid to diagnosis of congenital or acquired C1-Inhibitor deficiencies in patients at risk for or suspected to have C1-Inhibitor deficiency in human serum and sodium citrated plasma by means of automated Siemens Healthineers immuno-nephelometry systems. N Antiserum to Human C1-Inhibitor uses a calibration against an internal protein reference preparation.